ReP USP - Resultado da busca

Artigo de periodico
Lercanidipine reduces matrix metalloproteinase-2 activity and reverses vascular dysfunction in renovascular hypertensive rats (2008)
Martinez, Marcio L. L.; Castro, Michele M.; Rizzi, Elen; Fernandes, Karla; Demacq, Caroline; Bendhack, Lusiane Maria; Gerlach, Raquel Fernanda; Tanus-Santos, José Eduardo
Source: European Journal of Pharmacology. Unidades: FCFRP, FORP, FMRP
Subjects: HIPERTENSÃO, DOENÇAS VASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARTINEZ, Marcio L. L. et al. Lercanidipine reduces matrix metalloproteinase-2 activity and reverses vascular dysfunction in renovascular hypertensive rats. European Journal of Pharmacology, v. 591, n. 1-3, p. 224-230, 2008Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2008.06.096. Acesso em: 01 out. 2024.
APA
Martinez, M. L. L., Castro, M. M., Rizzi, E., Fernandes, K., Demacq, C., Bendhack, L. M., et al. (2008). Lercanidipine reduces matrix metalloproteinase-2 activity and reverses vascular dysfunction in renovascular hypertensive rats. European Journal of Pharmacology, 591( 1-3), 224-230. doi:10.1016/j.ejphar.2008.06.096
NLM
Martinez MLL, Castro MM, Rizzi E, Fernandes K, Demacq C, Bendhack LM, Gerlach RF, Tanus-Santos JE. Lercanidipine reduces matrix metalloproteinase-2 activity and reverses vascular dysfunction in renovascular hypertensive rats [Internet]. European Journal of Pharmacology. 2008 ; 591( 1-3): 224-230.[citado 2024 out. 01 ] Available from: https://doi.org/10.1016/j.ejphar.2008.06.096
Vancouver
Martinez MLL, Castro MM, Rizzi E, Fernandes K, Demacq C, Bendhack LM, Gerlach RF, Tanus-Santos JE. Lercanidipine reduces matrix metalloproteinase-2 activity and reverses vascular dysfunction in renovascular hypertensive rats [Internet]. European Journal of Pharmacology. 2008 ; 591( 1-3): 224-230.[citado 2024 out. 01 ] Available from: https://doi.org/10.1016/j.ejphar.2008.06.096
Artigo de periodico
Lercanidipine decreases vascular matrix metalloproteinase-2 activity and protects against vascular dysfunction in diabetic rats (2008)
Martinez, Marcio L. L.; Rizzi, Elen; Castro, Michele M.; Fernandes, Karla; Bendhack, Lusiane Maria; Gerlach, Raquel Fernanda; Tanus-Santos, José Eduardo
Source: European Journal of Pharmacology. Unidades: FMRP, FCFRP, FORP
Subjects: DIABETES MELLITUS, METALOPROTEINASES, DOENÇAS CARDIOVASCULARES, ESTRESSE OXIDATIVO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARTINEZ, Marcio L. L. et al. Lercanidipine decreases vascular matrix metalloproteinase-2 activity and protects against vascular dysfunction in diabetic rats. European Journal of Pharmacology, v. 599, n. 1-3, p. 110-116, 2008Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2008.10.007. Acesso em: 01 out. 2024.
APA
Martinez, M. L. L., Rizzi, E., Castro, M. M., Fernandes, K., Bendhack, L. M., Gerlach, R. F., & Tanus-Santos, J. E. (2008). Lercanidipine decreases vascular matrix metalloproteinase-2 activity and protects against vascular dysfunction in diabetic rats. European Journal of Pharmacology, 599( 1-3), 110-116. doi:10.1016/j.ejphar.2008.10.007
NLM
Martinez MLL, Rizzi E, Castro MM, Fernandes K, Bendhack LM, Gerlach RF, Tanus-Santos JE. Lercanidipine decreases vascular matrix metalloproteinase-2 activity and protects against vascular dysfunction in diabetic rats [Internet]. European Journal of Pharmacology. 2008 ; 599( 1-3): 110-116.[citado 2024 out. 01 ] Available from: https://doi.org/10.1016/j.ejphar.2008.10.007
Vancouver
Martinez MLL, Rizzi E, Castro MM, Fernandes K, Bendhack LM, Gerlach RF, Tanus-Santos JE. Lercanidipine decreases vascular matrix metalloproteinase-2 activity and protects against vascular dysfunction in diabetic rats [Internet]. European Journal of Pharmacology. 2008 ; 599( 1-3): 110-116.[citado 2024 out. 01 ] Available from: https://doi.org/10.1016/j.ejphar.2008.10.007
Artigo de periodico
Atorvastatin enhances sildenafil-induced vasodilation through nitric oxide-mediated mechanisms (2004)
Castro, Michele M.; Rizzi, Elen; Rascado, Ricardo Radighieri; Nagassaki, Sabrina; Bendhack, Lusiane Maria; Tanus-Santos, José Eduardo
Source: European Journal of Pharmacology. Unidades: FCFRP, FMRP
Assunto: FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CASTRO, Michele M. et al. Atorvastatin enhances sildenafil-induced vasodilation through nitric oxide-mediated mechanisms. European Journal of Pharmacology, v. 498, p. 189-194, 2004Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2004.07.051. Acesso em: 01 out. 2024.
APA
Castro, M. M., Rizzi, E., Rascado, R. R., Nagassaki, S., Bendhack, L. M., & Tanus-Santos, J. E. (2004). Atorvastatin enhances sildenafil-induced vasodilation through nitric oxide-mediated mechanisms. European Journal of Pharmacology, 498, 189-194. doi:10.1016/j.ejphar.2004.07.051
NLM
Castro MM, Rizzi E, Rascado RR, Nagassaki S, Bendhack LM, Tanus-Santos JE. Atorvastatin enhances sildenafil-induced vasodilation through nitric oxide-mediated mechanisms [Internet]. European Journal of Pharmacology. 2004 ; 498 189-194.[citado 2024 out. 01 ] Available from: https://doi.org/10.1016/j.ejphar.2004.07.051
Vancouver
Castro MM, Rizzi E, Rascado RR, Nagassaki S, Bendhack LM, Tanus-Santos JE. Atorvastatin enhances sildenafil-induced vasodilation through nitric oxide-mediated mechanisms [Internet]. European Journal of Pharmacology. 2004 ; 498 189-194.[citado 2024 out. 01 ] Available from: https://doi.org/10.1016/j.ejphar.2004.07.051

USP Schools

ReP

Filtros

Authors

Subjects

Indexado em